<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Anis Yohana Chaerunisaa</style></author><author><style face="normal" font="default" size="100%">Muhaimin Muhaimin</style></author><author><style face="normal" font="default" size="100%">Syamsurizal Syamsurizal</style></author><author><style face="normal" font="default" size="100%">Harizon Harizon</style></author><author><style face="normal" font="default" size="100%">Tiana Milanda</style></author><author><style face="normal" font="default" size="100%">Imam Adi Wicaksono</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Antifungal Activity of Neolignan Derivatives from Eusideroxylon zwageri Against Pathogenic Fungus Microsporum gypseum</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antifungal</style></keyword><keyword><style  face="normal" font="default" size="100%">Eusiderin</style></keyword><keyword><style  face="normal" font="default" size="100%">Eusideroxylon zwageri</style></keyword><keyword><style  face="normal" font="default" size="100%">Microsporum gypseum</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">993-999</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; Bulian wood (&lt;em&gt;Eusideroxylon zwageri&lt;/em&gt;) known as iron wood. It was known as wood source which fungi and insect resistant. These effects were interconnected with secondary metabolites contained within. &lt;strong&gt;Methods: &lt;/strong&gt;&lt;em&gt;Eusideroxylon zwageri&lt;/em&gt; wood powder was macerated with methanol and fractinated with n-Hexane, dichloromethane, ethyl acetate. Eusiderin I and Compound B were isolated from n-hexane fraction, while Compound C were isolated from dichloromethane fraction. Eusiderin I, compound A and Compound B were characterized using melting point, UV spectroscopy and compared with previous data. Antifungal activity test was conducted with &lt;em&gt;Microsporum gypseum&lt;/em&gt; using paper disc method. &lt;strong&gt;Results: &lt;/strong&gt;A research on antifungal activity of Neolignan derivatives from &lt;em&gt;Eusideroxylon zwageri &lt;/em&gt;against pathogenic fungus &lt;em&gt;Microsporum gypseum &lt;/em&gt;had been carried out. Eusiderin I, Compound B and Compound C were isolated from wood of &lt;em&gt;Eusideroxylon zwageri&lt;/em&gt;. All three compounds are white crystals with melting point in such 99-100 oC, 110-112 oC, 98-99 oC, respectively and UV spectrum data is similar to reference. The antifungal activity test of Eusiderin I, Compound B and Compound C from Bulian wood (&lt;em&gt;Eusideroxylon zwager&lt;/em&gt;i) to phatogen fungus of &lt;em&gt;Microsporum gypseum &lt;/em&gt;showed that with five different concentrations (5, 25, 50, 100 and 200 ppm), Eusiderin I was a potent antifungal because it had a strong activity in inhibiting the&lt;em&gt; Microsporum gypseum &lt;/em&gt;growth. The 5 days incubation test result showed that 50 ppm Eusiderin I could inhibit the &lt;em&gt;Microsporum gypseum&lt;/em&gt; colony growth. The 100 ppm Eusiderin I gave the most effective inhibition precentage because it could inhibit the &lt;em&gt;Microsporum gypseum &lt;/em&gt;colony growth (= 93.9%). &lt;strong&gt;Conclusion: &lt;/strong&gt;Based on this data, Eusiderin I can be indicated an antifungal candidate.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">993</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Anis Yohana Chaerunisaa&lt;sup&gt;1,&lt;/sup&gt;*, Muhaimin Muhaimin&lt;sup&gt;2,3&lt;/sup&gt;, Syamsurizal Syamsurizal&lt;sup&gt;2,3&lt;/sup&gt;, Harizon Harizon&lt;sup&gt;2&lt;/sup&gt;, Tiana Milanda&lt;sup&gt;4&lt;/sup&gt;, Imam Adi Wicaksono&lt;sup&gt;5 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmaceutic and Pharmaceutical Technology, Faculty of Pharmacy, Padjadjaran University, Jatinangor, 45363, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Chemistry Education, Faculty of Education, University of Jambi, Jambi, 36361, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Chemistry, Faculty of Science and Technology, University of Jambi, Jambi, 36361, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Pharmaceutical Biology, Faculty of Pharmacy, Padjadjaran University, Jatinangor, 45363, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Padjadjaran University, Jatinangor, 45363, INDONESIA.&lt;/p&gt;
</style></auth-address></record></records></xml>